CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Drug Discovery & Development
Original article

Before its recent Phase 3 LSD win, Definium modeled up to $70,000 a year for a therapy that could fill a clinical shift

Phase 3
Related Companies

Read the original article

Published by Drug Discovery & Development on August 21, 2026 5:29 PM

Read Original